Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Debbage

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Current Pharmaceutical Design|January 20, 2009
Targeted drugs and nanomedicine: present and futurePaul Debbage
Histochemistry and Cell Biology|October 1, 2008
Molecular imaging with nanoparticles: giant roles for dwarf actorsPaul Debbage, Werner Jaschke
Histochemistry and Cell Biology|November 17, 2018
Molecular imaging with nanoparticles: the dwarf actors revisited 10 years laterGudrun C Thurner, Paul Debbage
International Journal of Clinical Pharmacology and Therapeutics|December 24, 2011
Transbarrier targeting in the intestine: nanomedical options in oncologyPaul Debbage, Gudrun C Thurner
Histochemistry and Cell Biology|June 8, 2013
In focus in Prague: intermediate filamentsJürgen Roth, Paul Debbage, Pavel Hozák
International Journal of Radiation Biology|December 20, 2013
Proteomics of cancer stem cellsSergej Skvortsov, Paul Debbage, Ira Skvortsova
Nanoscale Advances|February 9, 2023
Albumin-based nanoparticles: small, uniform and reproducibleGudrun C Thalhammer-Thurner, Paul Debbage
International Journal of Molecular Sciences|August 27, 2021
Targeting Drug Delivery in the Elderly: Are Nanoparticles an Option for Treating Osteoporosis?Gudrun C Thurner, Johannes Haybaeck, Paul Debbage
Seminars in Cancer Biology|September 23, 2015
Radiation resistance: Cancer stem cells (CSCs) and their enigmatic pro-survival signalingIra Skvortsova, Paul Debbage, Vinod Kumar, et al.
Seminars in Cancer Biology|June 24, 2014
Crosstalk between DNA repair and cancer stem cell (CSC) associated intracellular pathwaysSergej Skvortsov, Paul Debbage, Peter Lukas, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Current Pharmaceutical Design|January 20, 2009
Targeted drugs and nanomedicine: present and futurePaul Debbage
Histochemistry and Cell Biology|October 1, 2008
Molecular imaging with nanoparticles: giant roles for dwarf actorsPaul Debbage, Werner Jaschke
Histochemistry and Cell Biology|November 17, 2018
Molecular imaging with nanoparticles: the dwarf actors revisited 10 years laterGudrun C Thurner, Paul Debbage
International Journal of Clinical Pharmacology and Therapeutics|December 24, 2011
Transbarrier targeting in the intestine: nanomedical options in oncologyPaul Debbage, Gudrun C Thurner
Histochemistry and Cell Biology|June 8, 2013
In focus in Prague: intermediate filamentsJürgen Roth, Paul Debbage, Pavel Hozák
International Journal of Radiation Biology|December 20, 2013
Proteomics of cancer stem cellsSergej Skvortsov, Paul Debbage, Ira Skvortsova
Nanoscale Advances|February 9, 2023
Albumin-based nanoparticles: small, uniform and reproducibleGudrun C Thalhammer-Thurner, Paul Debbage
International Journal of Molecular Sciences|August 27, 2021
Targeting Drug Delivery in the Elderly: Are Nanoparticles an Option for Treating Osteoporosis?Gudrun C Thurner, Johannes Haybaeck, Paul Debbage
Seminars in Cancer Biology|September 23, 2015
Radiation resistance: Cancer stem cells (CSCs) and their enigmatic pro-survival signalingIra Skvortsova, Paul Debbage, Vinod Kumar, et al.
Seminars in Cancer Biology|June 24, 2014
Crosstalk between DNA repair and cancer stem cell (CSC) associated intracellular pathwaysSergej Skvortsov, Paul Debbage, Peter Lukas, et al.
Pageof 3